XML 55 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Operating activities    
Net loss for the year $ (16,515,389) $ (8,563,473)
Items not affecting cash:    
Accretion 445,190 408,181
Amortization and depreciation 380,338 298,666
Impairment charges   78,456
Foreign exchange loss 20,904 36,530
Stock option expense 5,744,656 1,425,645
Interest income (406,132) (20,987)
Loss on write-off of sales tax recoverable 91,289  
(Gain) loss on divestment of mineral properties (29,148) 89,914
(Gain) loss on divestment of subsidiary (1,594,901)  
Loss (gain) on change in asset retirement obligation estimate 157,226 (1,719,943)
Unrealized gain on uranium investment   (1,554,000)
Gain on sale of uranium investment (35,000) (524,075)
Unrealized gain on marketable securities (1,057,405)  
Loss on investment in associate 586,900 355,735
Changes in non-cash working capital items:    
Receivables and prepaid expenses (715,928) (203,160)
Deposit - uranium investment (3,000,000)  
Restricted cash (50,049,202)  
Accounts payable and accrued liabilities (3,656,511) 5,921,147
Due to related parties 434,902 4,562
Net cash operating activities (69,198,211) (3,966,802)
Investing activities    
Acquisition of intangible assets (55,150) (17,241)
Acquisition of property, plant, and equipment (979,501) (300,737)
Mineral property expenditures (9,860,682) (2,357,254)
Proceeds from divestment of mineral properties 48,480 105,600
Cash acquired from Azarga asset acquisition   1,860,360
Transaction costs on Azarga asset acquisition   (3,252,264)
Deferred acquisition costs (6,009,303)  
Interest income received 406,132 20,987
Investment in uranium   (9,076,000)
Proceeds received from sale of uranium investment 4,245,000 6,975,000
Settlement of asset retirement obligation (11,324) (11,189)
Net cash investing activities (12,216,348) (6,052,738)
Financing activities    
Private placement proceeds 23,057,411 11,966,494
Share issue costs (1,473,875) (762,902)
Proceeds from exercise of warrants 2,452,227 2,633,029
Proceeds from exercise of stock options 1,177,093 288,572
Share subscriptions received 51,558,624  
Deferred financing costs (1,717,268)  
Lease payments (104,815) (37,588)
Net cash financing activities 74,949,397 14,087,605
Effect of foreign exchange on cash (211,309) (61,831)
Change in cash (6,676,471) 4,006,234
Cash, beginning of year 9,188,483 5,182,249
Cash, end of year $ 2,512,012 $ 9,188,483